Cetamina endovenosa como principal meio de ação rápida na suicidalidade: Revisão de Literatura

Abstract

Worldwide, around 800 thousand people die by suicide annualy and this number is also a consequence of the delay in therapeutic response. However, ketamine is an innovative and safe drug with a quick and effective response that has been used to contribute to the reduction of suicide rates. Unlike the traditional antidepressants, one of its advantages is the possibility of different routes of administration with a quick response.The objective of this study is to demonstrate that the administration of intravenous ketamine is effective, safe and the most mentioned in the literature in the immediate approach to suicide. For this, a search in the virtual databases PubMed, SiELO, BVS and Google Scholar was carried out for the terms "ketamine" and "suicide", including studies of reliability and methodological and scientific relevance, published since 2016, containing analyzes on suicide isolated or comorbid with affective disorders. The hypothesis to be studied is based on demonstrating that the intravenous application of ketamine provides more favorable results in the suicide prevention. Having a larger number of studies and more favorable results, especially in the psychiatric emergency environment. Therefore, it is expected that services that deal with suicidal crises will be able to establish protocols for intravenous ketamine infusion. As well, it is expected that new studies will be published incorporating more relevance to the data found so far, such that ketamine will soon be available for use in most mental health care services in the country.